Suboxone® Sales Estimated to Reach $1.4 Billion in 2012—More Than Viagra® or Adderall®

Sales data from the first three quarters of 2012 indicate that Suboxone retail sales in the U.S. will likely reach $1.4 billion this year—nearly a ten-fold increase over the $137.1 million in sales in 2006. Suboxone currently has the 28th highest retail sales of all prescription drugs in the U.S., up from 198th in 2006. Suboxone sales will likely continue to increase in light of new SAMHSA regulations allowing Opioid Treatment Programs (OTPs) to dispense a multiple days’ supply of take-home buprenorphine, the main ingredient in Suboxone, to eligible patients without having to adhere to previous length of time in treatment requirements. The steady and rapid increase in Suboxone sales suggests that the drug is being widely adopted in the treatment of opioid dependence, likely because of its effectiveness and because it can be prescribed in both private physicians’ offices and OTPs.

Further information is available at: http://www.cesar.umd.edu/cesar/cesarfax/vol21/21-49.pdf

 Source: Cesar Fax – December 10, 2012 Vol. 21, Issue 49

Comments

  1. Chris Kelly says:

    That is amazing, considering the special licensing requirements and patient limits, which are NOT put on any other medication in the USA. This effective medication should be available to anyone who wants it. All of the certified doctors here in Washington DC are currently at their 100 patient limit so people who live in DC have to travel to another State if they want burprenorphine treatment. This is also the case in other parts of the USA.

    Remove the special licensing requirements and the 100 patient limit.

  2. My question pertains to appropriate addiction counseling that should go along with those sales…. it has been my experience that physicians are not interested in that aspect of the treatment process and as a result don’t follow through with that aspect of the treatment process

We Value Your Feedback and Comments

*